V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20216662 | 20082570 | null | null | null | null | 2018-03-06 | null | null | null | LENVATINIB | 101184567 |
| 20216663 | 20082571 | 1.69 | 45.55 | Palliative (P) | 2016-07-24 | 2016-08-19 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + IRINOTECAN + MDG | 101371209 |
| 20216665 | 20082572 | null | null | null | 2017-07-02 | 2017-07-20 | Capecitabine (14 day) + Irinotecan | 02 | null | CAPECITABINE + IRINOTECAN | 100313118 |
| 20216666 | 20082573 | null | null | null | 2017-08-24 | 2017-08-29 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 100556188 |
| 20216667 | 20082574 | 1.58 | 92 | Palliative (P) | null | 2019-05-18 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100337551 |
| 20216668 | 20082575 | 1.86 | null | Palliative (P) | 2017-12-24 | 2018-01-09 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101365565 |
| 20216669 | 20082576 | 1.83 | 67 | Curative (C) | 2017-03-03 | 2017-03-06 | null | null | Y | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101816080 |
| 20216670 | 20082577 | 1.8 | 106.4 | Palliative (P) | null | 2018-08-25 | null | null | N | CAPECITABINE + IRINOTECAN | 100021770 |
| 20216673 | 20082579 | 1.74 | 87 | null | 2017-02-12 | 2017-02-18 | null | null | Y | CAPECITABINE + IRINOTECAN | 101225051 |
| 20216674 | 20082580 | 1.69 | 0 | Palliative (P) | 2016-11-27 | 2016-12-07 | Capecitabine (14 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 101130087 |
| 20216675 | 20082581 | null | null | null | 2018-04-22 | 2018-04-28 | CAPECITABINE + MITOMYCIN + RT | 02 | null | CAPECITABINE + MITOMYCIN + RT | 101344685 |
| 20216678 | 20082582 | null | null | null | null | 2018-06-26 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 100503453 |
| 20216679 | 20082583 | 1.68 | 62 | Neo-adjuvant (N) | null | 2017-05-02 | null | null | Y | CISPLATIN + ETOPOSIDE | 100067840 |
| 20216681 | 20082585 | 1.66 | 112 | null | null | 2018-09-01 | null | null | null | CAPECITABINE + IRINOTECAN | 101486881 |
| 20216682 | 20082586 | null | null | null | 2016-03-30 | 2016-03-31 | ECarboX | null | null | CETUXIMAB + IRINOTECAN + MDG | 100053276 |
| 20216683 | 20082587 | null | null | null | 2017-12-29 | 2018-01-05 | null | null | null | CISPLATIN + ETOPOSIDE | 100571906 |
| 20216684 | 20082588 | null | null | null | 2017-04-04 | 2017-04-11 | LENVATINIB | 02 | null | LENVATINIB | 100106432 |
| 20216685 | 20082589 | null | null | null | null | 2018-05-20 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 101798170 |
| 20216686 | 20082590 | null | null | null | 2018-08-06 | 2018-08-06 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | null | null | CETUXIMAB + IRINOTECAN + MDG | 100868981 |
| 20216687 | 20082591 | 1.73 | 50.3 | Neo-adjuvant (N) | 2016-11-18 | 2016-12-23 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100742205 |
| 20216688 | 20082592 | null | null | null | 2018-11-03 | 2018-11-14 | Cisplatin + Etoposide (3 day) | 02 | null | CISPLATIN + ETOPOSIDE | 100603807 |
| 20216690 | 20082594 | 1.52 | 72 | Palliative (P) | null | 2017-07-10 | ECarboX | 02 | N | CAPECITABINE + IRINOTECAN | 101094116 |
| 20216691 | 20082595 | 1.66 | 67.1 | Palliative (P) | 2019-12-24 | 2020-01-02 | ECF | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101511250 |
| 20216695 | 20082597 | 1.65 | 84.4 | Palliative (P) | 2018-06-14 | 2018-08-02 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + IRINOTECAN + MDG | 101787616 |
| 20216696 | 20082598 | null | null | null | 2016-11-27 | 2016-11-28 | CAPECITABINE + MITOMYCIN + RT | 02 | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100983537 |
| 20216698 | 20082600 | null | null | null | null | 2020-03-30 | null | null | null | HCX | 101285841 |
| 20216699 | 20082601 | null | null | null | 2017-10-14 | 2017-11-02 | Capecitabine (14 day) + Irinotecan | 02 | null | CAPECITABINE + IRINOTECAN | 101312469 |
| 20216700 | 20082602 | 1.64 | 66.8 | Palliative (P) | null | 2018-06-07 | null | null | N | CISPLATIN + ETOPOSIDE | 101779223 |
| 20216701 | 20082603 | null | null | null | 2018-10-07 | 2018-10-07 | CAPECITABINE + CISPLATIN + Trastuzumab | null | null | HCX | 100720289 |
| 20216703 | 20082605 | 1.49 | 72 | Neo-adjuvant (N) | 2017-01-16 | 2017-01-24 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | null | CAPECITABINE + MITOMYCIN + RT | 100399522 |
| 20216704 | 20082606 | 1.68 | 94.8 | Palliative (P) | 2018-10-21 | 2019-11-05 | CISPLATIN + ETOPOSIDE | 02 | N | CISPLATIN + ETOPOSIDE | 100428088 |
| 20216705 | 20082607 | null | null | null | 2016-06-18 | 2016-06-18 | null | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100139758 |
| 20216706 | 20082608 | 1.69 | 0 | null | null | 2017-03-25 | null | null | Y | LENVATINIB | 100410699 |
| 20216707 | 20082609 | 1.65 | null | Palliative (P) | null | 2018-07-15 | null | null | N | LENVATINIB | 101652648 |
| 20216709 | 20082611 | 1.7 | 56.6 | Palliative (P) | 2021-02-09 | 2021-02-15 | ECarboX | 02 | N | HCX | 100174133 |
| 20216710 | 20082612 | 1.85 | 119 | Palliative (P) | 2019-06-25 | 2019-06-25 | null | null | Y | HCX | 100887957 |
| 20216711 | 20082613 | null | null | null | 2017-06-22 | 2017-06-22 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | null | CETUXIMAB + IRINOTECAN + MDG | 101139585 |
| 20216712 | 20082614 | 1.63 | 71 | Palliative (P) | 2017-12-03 | 2017-12-08 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 100852321 |
| 20216714 | 20082616 | 1.88 | null | Palliative (P) | null | 2018-06-24 | null | null | N | LENVATINIB | 101092613 |
| 20216715 | 20082617 | null | null | null | 2019-03-26 | 2019-04-11 | ECF | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101147984 |
| 20216718 | 20082620 | null | null | null | 2018-12-25 | 2018-12-25 | LENVATINIB | 99 | null | LENVATINIB | 101828855 |
| 20216720 | 20082622 | null | null | null | null | 2020-07-16 | null | null | null | CAPECITABINE + IRINOTECAN | 100743400 |
| 20216722 | 20082623 | 1.79 | 103 | Palliative (P) | null | 2017-03-01 | null | null | N | CAPECITABINE + IRINOTECAN | 100987004 |
| 20216723 | 20082624 | 1.78 | 100 | Palliative (P) | 2016-03-19 | 2016-04-07 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 100300263 |
| 20216724 | 20082625 | null | 76.3 | 03 | null | 2017-02-02 | null | null | N | CAPECITABINE + IRINOTECAN | 100546967 |
| 20216725 | 20082626 | 1.63 | 81.95 | 02 | null | 2017-10-26 | null | null | N | LENVATINIB | 100872703 |
| 20216726 | 20082627 | 1.71 | 93.65 | null | 2021-06-17 | 2021-07-10 | CAPECITABINE + MITOMYCIN + RT | 02 | null | CAPECITABINE + MITOMYCIN + RT | 101614751 |
| 20216727 | 20082628 | null | null | null | 2016-11-03 | 2016-11-16 | ECarboX | N | null | CAPECITABINE + IRINOTECAN | 100346595 |
| 20216730 | 20082630 | 1.55 | 98 | Palliative (P) | 2019-12-12 | 2020-01-03 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 100549028 |
| 20216733 | 20082633 | null | null | null | 2018-02-21 | 2018-02-23 | null | null | null | CISPLATIN + ETOPOSIDE | 100943886 |